Efficacy, Safety and Tolerability of Multiple Doses of Valsartan in Children With Hypertension With or Without CKD
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 127 participants.
Also called NCT01617681
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 127 participants
- Sponsor
- Registry
-
NCT01617681 -
2011-005991-40
-
- Other papers using this trial's data
- Efficacy and safety of valsartan in children aged 1-5 years with hypertension, with or without chronic kidney disease: a randomized, double-blind study followed by open-label phase
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Belgium, Brazil, France, Germany, Guatemala, Hungary, Italy, Lithuania, Poland
- Registry status
- Completed
Technical summary
Registry record NCT01617681. Randomized; triple masking; primary purpose treatment. Start 2012-11-08 (actual); primary completion 2017-01-24 (actual). Results posted on 2017-09-27.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy, Safety and Tolerability of Multiple Doses of Valsartan in Children With Hypertension With or Without CKD
- Condition
- Pediatric Hypertension With or Without CKD
- Intervention (Drug)
- VAL489
- Intervention (Drug)
- VAL489 matching placebo
- Lead sponsor
- Novartis Pharmaceuticals
Record details
- Record id
cardio:ct-nct01617681- Content hash
6294318962e86b753c587b9a1216a9d34b6fce9c784f0b0b498ba3f2290a22f7